MedTrace Logo

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention

NCT05910112 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-06-18

No results posted yet for this study

Summary

The PROSPECT study aims to look at the number of problems or side effects which occur after patients have had a procedure completed to remove fluid or air from the space between the lung and the chest wall. Other information will also be collected to see whether anything else affects which patients have problems after the procedure such as bleeding or infection. This study will also investigate whether it is possible to find out which patients are likely to feel a lot better after the procedure. Not all patients feel significantly better but it is not clear why this is. There are a number of different reasons patients may not feel better, for example if the lung is not able to fully re-expand. The study aims to look at whether it is possible to predict these problems before the procedure using ultrasound. If it is possible to find the answers to some of these questions it might be possible to prevent patients undergoing treatments which are not likely to benefit them. The study will use information already collected as part of clinical care, as well as questionnaires from patients receiving care at a variety of centres. The different features of these centres will also be considered in analysis.

Conditions

  • Pleural Diseases
  • Pleural Mesothelioma
  • Pneumothorax
  • Pleural Effusion
  • Pleural Infection
  • Pleural Neoplasms
  • Pleural Metastases
  • Pleural Effusion, Malignant
  • Procedural Complication
  • Complications, Pulmonary

Interventions

PROCEDURE

Pleural interventions

eg thoracocentesis, chest drain, indwelling pleural catheters, thoracoscopy

Sponsors & Collaborators

  • Beckton Dickinson

    collaborator UNKNOWN

  • University of Oxford

    lead OTHER

Principal Investigators

  • Najib Rahman, DPhil · University of Oxford

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910112 on ClinicalTrials.gov